HCMT
PGNX

Highland Capital Management (Texas)’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Highland Capital Management (Texas)’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$4.42M Buy
+716,880
New +$3.46M 0.26% 67
2014
Q4 		– Sell
-1,589,363
Closed -$8.25M – 267
2014
Q3 		$8.25M Hold
1,589,363
– – 0.31% 83
2014
Q2 		$6.85M Buy
1,589,363
+205,634
+15% +$785K 0.25% 87
2014
Q1 		$5.66M Sell
1,383,729
-82,653
-6% -$423K 0.23% 89
2013
Q4 		$7.82M Sell
1,466,382
-720,471
-33% -$3.17M 0.43% 59
2013
Q3 		$11M Hold
2,186,853
– – 0.71% 42
2013
Q2 		$9.75M Buy
+2,186,853
New +$9.81M 0.75% 36

Other funds holding PGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Highland Capital Management (Texas)'s PGNX Position: Q2 2019 in Review

Highland Capital Management (Texas) opened a new position in Progenics Pharmaceuticals Inc (PGNX) in Q2 2019: 716,880 shares worth $4.42M. The stake represents 0.26% of the portfolio and ranks #67 among its holdings. This is a return to the name: Highland Capital Management (Texas) previously reported a position in PGNX as recently as Q3 2014.

Highland Capital Management (Texas) first reported a position in PGNX in Q2 2013 and has held it in 7 quarters since. The position peaked at $11M in Q3 2013. 142 funds tracked by Wall St. Rank hold PGNX as of Q2 2019.

  • Highland Capital Management (Texas) held 716,880 shares of Progenics Pharmaceuticals Inc worth $4.42M as of Q2 2019.
  • Progenics Pharmaceuticals Inc was a new Highland Capital Management (Texas) position in Q2 2019.
  • Progenics Pharmaceuticals Inc made up 0.26% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #67 holding.
  • Highland Capital Management (Texas) first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and has held it in 7 quarters since.
  • Highland Capital Management (Texas)'s Progenics Pharmaceuticals Inc position peaked at $11M in Q3 2013.
  • 142 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.